• Follow the Money: Rare Muscle Disease Treatment, Huntington’s Disease Trial, More

    Feb 26, 2025, 08:11 by User Not Found
    Clinical Research News | Abcuro is advancing to a Phase II/III trial to treat a rare, chronic inflammatory muscle disease called inclusion body myositis; Atalanta Therapeutics plans to start Phase I clinical trials of the company’s RNAi therapies for a genetic form of childhood epilepsy and for Huntington’s disease; and more.
    Full story
  • Oxford Nanopore expands compatibility with 10x Genomics to unlock deeper insights in single-cell transcriptomics

    Feb 25, 2025, 08:08 by
    Oxford Nanopore has expanded its collaboration with 10x Genomics to help improve single-cell transcriptomics research.
    Full story
  • Regulators Support ‘Pragmatism’ in Clinical Trials

    Feb 25, 2025, 01:00 by User Not Found
    Clinical Research News | A panel of experts from inside several major pharma companies discussed regulatory initiatives around pragmatic trials in depth at the recent Summit for Clinical Trial Ops Executives (SCOPE). Henry Wei, M.D., head of development innovation at Regeneron; Gracy Crane, international regulatory policy lead for real-world data at Roche Products Limited; Melodi J. McNeil, director of regulatory policy and intelligence at AbbVie; Stephanie Derbyshire, clinical operations portfolio leader at Roche; and Kevin Bugin, associate vice president of global regulatory policy and intelligence at Amgen were all part of the panel.
    Full story
  • Velsera Drives Momentum in 2024 with Key Platform Advancements and Strategic Growth

    Feb 21, 2025, 08:20 by
    Full story
  • Scope of Things: SCOPE 2025, Participant Engagement Award Winners, AI Helping With Clinical Trials, More

    Feb 21, 2025, 01:00 by User Not Found
    Clinical Research News | In this month's episode of the Scope of Things, host Deborah Borfitz provides the latest on new criteria for defining and diagnosing obesity, the case for including pregnant women in vaccine trials, an inert gas being tested as an Alzheimer’s treatment, and more.
    Full story
  • Celerion Expands UK Phase 1 Clinical Research Operations With New Agreement to Relocate to Queen’s University Belfast’s iREACH Health – Clinical Research Innovation Center

    Feb 20, 2025, 08:25 by
    Celerion proudly announces a new agreement to relocate its U.K. Phase 1 clinical research operations to iREACH Health.
    Full story
  • USC to Use Generative AI to Make Cancer Clinical Trials More Efficient

    Feb 20, 2025, 01:00 by User Not Found
    Clinical Research News | The Norris Comprehensive Cancer Center, owned and operated by the University of Southern California (USC) through its Keck School of Medicine, will serve as the initial testing ground for a platform powered by generative artificial intelligence (AI) that is designed to streamline clinical trial operations. This is the first U.S.-based academic site in the research network of California startup company Ryght.
    Full story
  • CluePoints named as Finalist in 2025 ACDM Awards

    Feb 19, 2025, 08:58 by
    CluePoints, provider of leading statistical and AI-driven software solutions, has been shortlisted for “Team Excellence in the Management of Clinical Data” at the 2025 ACDM Awards.
    Full story
  • Fraud and Misconduct in Clinical Trials Not a Trivial Matter

    Feb 18, 2025, 01:00 by User Not Found
    Clinical Research News | In a debate at the recent Summit for Clinical Ops Executives (SCOPE) over whether fraud and misconduct in clinical trials represent a marginal nuisance or a major problem, the argument for it being a serious situation easily won the day based on a show of hands in the room. Making the case for an embarrassment of breaches was Jonathan Rowe, head of R&D quality, operations and risk management at management consulting and technology firm ZS.
    Full story
  • Phastar Secures SCOPE US ‘Best in Show’ Accolade for Clinical Intelligence Platform

    Feb 14, 2025, 07:52 by
    Phastar, a global specialist biometrics & data science contract research organization (CRO), won a Best of Show Award at Summit for Clinical Ops Executives (SCOPE) US 2025.
    Full story
  • Why the Human Touch is Still Present in the Technological Era

    Feb 14, 2025, 01:00 by User Not Found
    Clinical Research News | The healthcare industry has experienced tremendous growth in the use of artificial intelligence (AI) and large language models (LLMs) over the past decade, both of which are already impacting how precision medicine is applied. AI plays a key role in identifying patterns within complex datasets, improving accuracy, and facilitating the exploration of vast volumes of clinical and ‘omics-based research data.
    Full story
  • Bioanalytical CRO, Veloxity Labs, Partners with Aplos Analytics to Transform Pharmacokinetic and Toxicokinetic Analysis

    Feb 13, 2025, 08:26 by
    Veloxity Labs clients can now pair PK/TK projects with their bioanalysis for lightning-fast, highly accurate results in minutes.
    Full story
  • Yourgene Health Launches IONA Care+ Non-invasive Prenatal Testing Service

    Feb 13, 2025, 08:26 by
    Full story
  • Crosstree Capital Partners’ Shane Senior Discusses AI’s Disruption of Clinical Trials

    Feb 12, 2025, 01:00 by User Not Found
    Clinical Research News | At the Venture, Innovation and Partnering forum at last week’s SCOPE Summit in Orlando, Shane Senior, the Managing Director and Owner of Crosstree Capital Partners, delivered a bit of an ultimatum: evolve or die! While the decentralized trial revolution never quite materialized, the AI revolution underway in clinical trials is poised for more dramatic change than ever in the next five years.
    Full story
  • Walgreens Clinical Trials Puts Focus on Patient ‘Readiness’ for Recruitment

    Feb 11, 2025, 01:00 by User Not Found
    Clinical Research News | Incorporating the lived experience of patients into strategic planning around clinical trials, and outreach to historically under-represented communities, are central features of the operational model of Walgreens Clinical Trials. The key is to foster a sense of trust and long-term connection with different population groups—not show up suddenly and unexpectedly with a flashy recruitment campaign that is destined to “fall flat.”
    Full story
  • Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis

    Feb 7, 2025, 08:25 by
    A clinical trial for people living with the life-threatening lung condition Progressive Pulmonary Fibrosis (PPF) is using deep learning imaging technology to evaluate a new treatment to tackle the condition for the first time.
    Full story
  • Inizio accelerates growth with a trio of strategic leadership appointments

    Feb 7, 2025, 08:25 by
    Full story
  • Anju, Biorce, Medidata, Phastar Take Home Best of Show Awards from SCOPE 2025

    Feb 6, 2025, 06:58 by User Not Found
    Clinical Research News | Winners were named in the 2025 SCOPE Best of Show Awards yesterday. With more than 60 new product finalists on display on the Exhibit Hall floor and more than 300 attendees voting on their favorite new products, the Best of Show program at SCOPE highlights the very best in innovation and new technologies in clinical research.
    Full story
  • Narrowing the Gap Between Clinical Research and Clinical Care

    Feb 5, 2025, 07:17 by User Not Found
    Clinical Research News | The growing convergence between clinical research and clinical care—and ways the second Trump administration will be encouraging and supporting movement in that direction—was the topic of the opening keynote presentation made at this week’s Summit for Clinical Ops Executives (SCOPE) in Orlando.
    Full story
  • Synexa Life Sciences Achieves Highest Level My Green Lab Certification, Reinforcing Commitment to Lab Sustainability

    Feb 4, 2025, 08:58 by
    Synexa Life Sciences has achieved the My Green Lab Certification at the highest ‘Green’ level at its Cape Town, South Africa facility.
    Full story
  • «
  • 31
  • 32
  • 33
  • 34 (current)
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • »